Cardiovascular Disease Risk Research

Is your LDL cholesterol between 70 and 190? If so, you may be at risk for major cardiovascular events even if you are not experiencing heart symptoms. Preventing a heart attack and stroke is the best line of defense. Cardiovascular disease can cause major cardiovascular events including heart attack, stroke, and cardiovascular death. Research on new medications is needed to help prevent major cardiovascular events.

We are conducting a research study for volunteers that will evaluate an investigational preventative medication for patients with an increased risk of Cardiovascular Disease.

You may be eligible if you:

• Are 40-79 years old
• Have LDL cholesterol levels between 70 and 190 mg/dL
• Have NOT had a major cardiovascular event such as heart attack or stroke
• Are at an increased risk of a first major cardiovascular event, defined by one or more of the following:
  • Coronary artery disease (CAD)
  • High coronary artery calcium (CAC) score
  • Elevated Lipoprotein (a) or hsCRP
  • South Asian Ancestry
  • A family member with cardiovascular disease
  • Pregnancy complications (preeclampsia, gestational hypertension, or gestational diabetes)
  • Metabolic syndrome
  • Chronic Inflammatory disorders including rheumatoid arthritis, lupus (SLE), psoriasis (>10% of the body), Crohn’s disease, ulcerative colitis, or HIV/AIDS

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for time and travel. No health insurance is required to participate.

For more information call

(904) 621-0390

Or sign up below, and our friendly staff will call you!

High LDL Cholesterol Research 

Dyslipidemia is one of the major risks for the leading cause of mortality worldwide, cardiovascular disease. Dyslipidemia means abnormal levels of fats (lipids) in the blood. Extra fats in the blood can accumulate in the arteries, increasing the risk of heart disease, heart attack, and stroke. A particularly dangerous type of fat is low-density lipoprotein cholesterol, often abbreviated to LDL-C. Statins have traditionally been the go-to medication to treat high cholesterol, but some patients continue to have persistently high LDL-C despite taking these medications. Some researchers hope to fight high cholesterol using a new class of medication called PCSK9 inhibitors that may help the body break down LDL-C and reduce cholesterol levels. 

Nature Coast Clinical Research – Inverness is conducting a research study to evaluate a new investigational PCSK9 inhibitor medication for dyslipidemia. 

You may be eligible to participate if you: 

• Are 18-75 years old 
• Have high LDL-C Cholesterol (70-189) 
• Are on daily moderate or high-dose statin therapy 
  • Atorvastatin 10+ mg 
  • Lovastatin 40+ mg 
  • Pravastatin 40+ mg 
  • Rosuvastatin 5+ mg 
  • Simvastatin 40+ mg 

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for study-related time and travel. No health insurance is required to participate. 

For more information call 

(352) 341-2100 

Or sign up below, and our friendly staff will call you! 

High LDL Cholesterol Research 

Dyslipidemia is one of the major risks for the leading cause of mortality worldwide, cardiovascular disease. Dyslipidemia means abnormal levels of fats (lipids) in the blood. Extra fats in the blood can accumulate in the arteries, increasing the risk of heart disease, heart attack, and stroke. A particularly dangerous type of fat is low-density lipoprotein cholesterol, often abbreviated to LDL-C. Statins have traditionally been the go-to medication to treat high cholesterol, but some patients continue to have persistently high LDL-C despite taking these medications. Some researchers hope to fight high cholesterol using a new class of medication called PCSK9 inhibitors that may help the body break down LDL-C and reduce cholesterol levels. 

Jacksonville Center for Clinical Research is conducting a research study to evaluate a new investigational PCSK9 inhibitor medication for dyslipidemia. 

You may be eligible to participate if you: 

• Are 18-75 years old 
• Have high LDL-C Cholesterol (70-189) 
• Are on daily moderate or high-dose statin therapy 
  • Atorvastatin 10+ mg 
  • Lovastatin 40+ mg 
  • Pravastatin 40+ mg 
  • Rosuvastatin 5+ mg 
  • Simvastatin 40+ mg 

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for study-related time and travel. No health insurance is required to participate. 

For more information call 

(904) 730-0166 

Or sign up below, and our friendly staff will call you! 

Cardiovascular Disease Risk Research 

 Is your LDL cholesterol between 70 and 190? If so, you may be at risk for major cardiovascular events even if you are not experiencing heart symptoms. Preventing a heart attack and stroke is the best line of defense. Cardiovascular disease can cause major cardiovascular events including heart attack, stroke, and cardiovascular death. Research on new medications is needed to help prevent major cardiovascular events. 

We are conducting a research study for volunteers that will evaluate an investigational preventative medication for patients with an increased risk of Cardiovascular Disease. 

You may be eligible if you:

• Are 40-79 years old
• Have LDL cholesterol levels between 70 and 190 mg/dL
• Have NOT had a major cardiovascular event such as heart attack or stroke
• Are at an increased risk of a first major cardiovascular event, defined by one or more of the following:
  • Coronary artery disease (CAD)
  • High coronary artery calcium (CAC) score
  • Elevated Lipoprotein (a) or hsCRP
  • South Asian Ancestry
  • A family member with cardiovascular disease
  • Pregnancy complications (preeclampsia, gestational hypertension, or gestational diabetes)
  • Metabolic syndrome
  • Chronic Inflammatory disorders including rheumatoid arthritis, lupus (SLE), psoriasis (>10% of the body), Crohn’s disease, ulcerative colitis, or HIV/AIDS

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for time and travel. No health insurance is required to participate. 

For more information call
(904) 209-0043
Or sign up below, and our friendly staff will call you!